Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

434
HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM THE PHASE 3 CANDOR STUDY COMPARING CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB TO CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
D.S. Siegela, K. Weiselb, A. Zahlten-Kumelic, R. Medhekarc, S. Saprac, B. Dingc, X. Leleud
a John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, United States
b Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
c Amgen Inc., Thousand Oaks, United States
d Hôpital Claude Huriez, Lille, France
Lido
2539
Vezes
que se leu este artigo
1232
Total PDF
1307
Total HTML
Compartilhar estatísticas
Informação do artigo
ISSN: 25311379
Idioma original: Inglês
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2025 7 29 20 49
2025 6 35 22 57
2025 5 38 18 56
2025 4 30 17 47
2025 3 48 10 58
2025 2 46 21 67
2025 1 31 19 50
2024 12 28 13 41
2024 11 31 17 48
2024 10 28 13 41
2024 9 24 15 39
2024 8 33 31 64
2024 7 20 20 40
2024 6 18 18 36
2024 5 20 18 38
2024 4 18 17 35
2024 3 27 22 49
2024 2 21 18 39
2024 1 16 25 41
2023 12 20 22 42
2023 11 23 30 53
2023 10 13 37 50
2023 9 22 35 57
2023 8 18 15 33
2023 7 17 17 34
2023 6 14 14 28
2023 5 21 13 34
2023 4 19 2 21
2023 3 21 12 33
2023 2 15 17 32
2023 1 12 8 20
2022 12 21 19 40
2022 11 22 28 50
2022 10 26 20 46
2022 9 34 24 58
2022 8 30 31 61
2022 7 14 34 48
2022 6 15 25 40
2022 5 16 22 38
2022 4 11 32 43
2022 3 12 14 26
2022 2 13 24 37
2021 1 9 13 22
2021 12 11 22 33
2021 11 14 17 31
2021 10 16 36 52
2021 9 20 31 51
2021 8 25 33 58
2021 7 22 35 57
2021 6 17 22 39
2021 5 17 34 51
2021 4 88 50 138
2021 3 30 32 62
2021 2 25 24 49
2020 1 10 9 19
2020 12 17 13 30
2020 11 16 12 28
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Hematology, Transfusion and Cell Therapy